Lescarden’s Catrix Wound Dressing utilizes bovine cartilage that has been refined into a fine, white powder. It has been shown in extensive clinical testing to be an effective aid in the healing of wounds that are resistant to the healing process. The product has been approved by the FDA for the management of first and second degree burns as well as decubitus ulcers, venous stasis and diabetic ulcers and post-radiation dermatitis.
The Catrix Wound Dressing is currently being distributed in Spain by Smith and Nephew. Regulatory marketing approvals and product reimbursement arrangements are being secured, and it is anticipated that product launch will commence in the first quarter of 2009.
William Luther, president of Lescarden, said: “We are pleased with this new distribution agreement, which should enable us to make a significant penetration, for the first time, into one of the most important European markets for our products.”